$3.32T
Total marketcap
$176.59B
Total volume
BTC 57.13%     ETH 11.96%
Dominance

CTT Pharmaceutical CTTH Stock

$0.04   -11.670284%
Add to favorites
Market Cap
$2.35M
LOW - HIGH [24H]
$0.05 - $0.06
VOLUME [24H]
$36.36K
P/E Ratio
0
Earnings per share
-$0.01

CTT Pharmaceutical Price Chart

Sorry, that's all we've gotfor now...

CTT Pharmaceutical CTTH Financial and Trading Overview

CTT Pharmaceutical stock price 0.04 USD
Previous Close {summary_details__previousClose}
Open {summary_details__open}
Bid {summary_details__bid} x {summary_details__bidSize}
Ask {summary_details__ask} x {summary_details__askSize}
Day's Range 0.0085 - 0.0085 USD
52 Week Range 0.0085 - 0.07 USD
Volume {summary_details__volume}
Avg. Volume {summary_details__averageVolume}
Market Cap {summary_details__marketCap}
Beta (5Y Monthly) {summary_details__beta}
PE Ratio (TTM) {summary_details__trailingPE}
EPS (TTM) -0.01 USD
Forward Dividend & Yield {summary_details__dividendRate} ({summary_details__dividendYield})
Ex-Dividend Date {summary_details__exDividendDate}
1y Target Est {financial_data__targetMeanPrice}

CTTH Valuation Measures

Enterprise Value {default_key_statistics__enterpriseValue}
Trailing P/E {summary_details__trailingPE}
Forward P/E {summary_details__forwardPE}
PEG Ratio (5 yr expected) {default_key_statistics__pegRatio}
Price/Sales (ttm) {summary_details__priceToSalesTrailing12Months}
Price/Book (mrq) {default_key_statistics__priceToBook}
Enterprise Value/Revenue {default_key_statistics__enterpriseToRevenue}
Enterprise Value/EBITDA {default_key_statistics__enterpriseToEbitda}

Trading Information

CTT Pharmaceutical Stock Price History

Beta (5Y Monthly) {default_key_statistics__beta}
52-Week Change {default_key_statistics__52WeekChange}
S&P500 52-Week Change {default_key_statistics__SandP52WeekChange}
52 Week High {summary_details__fiftyTwoWeekHigh}
52 Week Low {summary_details__fiftyTwoWeekLow}
50-Day Moving Average {summary_details__fiftyDayAverage}
200-Day Moving Average {summary_details__twoHundredDayAverage}

CTTH Share Statistics

Avg. Volume (3 month) {summary_details__averageVolume}
Avg. Daily Volume (10-Days) {summary_details__averageDailyVolume10Day}
Shares Outstanding {default_key_statistics__sharesOutstanding}
Float {default_key_statistics__floatShares}
Short Ratio {default_key_statistics__shortRatio}
% Held by Insiders {default_key_statistics__heldPercentInsiders}
% Held by Institutions {default_key_statistics__heldPercentInstitutions}
Shares Short {default_key_statistics__sharesShort}
Short % of Float {default_key_statistics__shortPercentOfFloat}
Short % of Shares Outstanding {default_key_statistics__sharesPercentSharesOut}

Dividends & Splits

Trailing Annual Dividend Rate {summary_details__trailingAnnualDividendRate}
Trailing Annual Dividend Yield {summary_details__trailingAnnualDividendYield}
5 Year Average Dividend Yield {summary_details__fiveYearAvgDividendYield}
Payout Ratio {summary_details__payoutRatio}
Last Split Factor {default_key_statistics__lastSplitFactor}

Financial Highlights

Fiscal Year

Fiscal Year Ends {default_key_statistics__lastFiscalYearEnd}
Most Recent Quarter (mrq) {default_key_statistics__mostRecentQuarter}
Next Fiscal Year End {default_key_statistics__nextFiscalYearEnd}

Profitability

Profit Margin {financial_data__profitMargins}
Operating Margin (ttm) {financial_data__operatingMargins}
Gross Margin {financial_data__grossMargins}
EBITDA Margin {financial_data__ebitdaMargins}

Management Effectiveness

Return on Assets (ttm) {financial_data__returnOnAssets}
Return on Equity (ttm) {financial_data__returnOnEquity}

Income Statement

Revenue (ttm) {financial_data__totalRevenue}
Revenue Per Share (ttm) {financial_data__revenuePerShare}
Quarterly Revenue Growth (yoy) {financial_data__revenueGrowth}
Gross Profit (ttm) {financial_data__grossProfits}
EBITDA {financial_data__ebitda}
Net Income Avi to Common (ttm) {default_key_statistics__netIncomeToCommon}
Diluted EPS (ttm) {default_key_statistics__trailingEps}
Quarterly Earnings Growth (yoy) {default_key_statistics__earningsQuarterlyGrowth}

Balance Sheet

Total Cash (mrq) {financial_data__totalCash}
Total Cash Per Share (mrq) {financial_data__totalCashPerShare}
Total Debt (mrq) {financial_data__totalDebt}
Total Debt/Equity (mrq) {financial_data__debtToEquity}
Current Ratio (mrq) {financial_data__currentRatio}
Book Value Per Share (mrq) {default_key_statistics__bookValue}

Cash Flow Statement

Operating Cash Flow (ttm) {financial_data__operatingCashflow}
Levered Free Cash Flow (ttm) {financial_data__freeCashflow}

Profile of CTT Pharmaceutical

Country United States
State {summary_profile__state}
City {summary_profile__city}
Address {summary_profile__address1}
ZIP {summary_profile__zip}
Phone {summary_profile__phone}
Website {summary_profile__website}
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees {summary_profile__fullTimeEmployees}

{summary_profile__longBusinessSummary}

Q&A For CTT Pharmaceutical Stock

What is a current CTTH stock price?

CTT Pharmaceutical CTTH stock price today per share is 0.04 USD.

How to purchase CTT Pharmaceutical stock?

You can buy CTTH shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for CTT Pharmaceutical?

The stock symbol or ticker of CTT Pharmaceutical is CTTH.

Which industry does the CTT Pharmaceutical company belong to?

The CTT Pharmaceutical industry is Drug Manufacturers-Specialty & Generic.

How many shares does CTT Pharmaceutical have in circulation?

The max supply of CTT Pharmaceutical shares is 57.68M.

What is CTT Pharmaceutical Price to Earnings Ratio (PE Ratio)?

CTT Pharmaceutical PE Ratio is now.

What was CTT Pharmaceutical earnings per share over the trailing 12 months (TTM)?

CTT Pharmaceutical EPS is -0.01 USD over the trailing 12 months.

Which sector does the CTT Pharmaceutical company belong to?

The CTT Pharmaceutical sector is Healthcare.

✨New! Portfolio🚀